Compounds > deferoxamine

deferoxamine and paclitaxel

deferoxamine has been researched along with paclitaxel in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Choi, BM; Chung, HT; Kang, CL; Kim, JD; Pae, HO; Yoo, JC1
Haskova, P; Jansova, H; Kalinowski, DS; Machacek, M; Potuckova, E; Richardson, DR; Richardson, V; Simunek, T; Tichotova, L; Vavrova, A1
Ferreira, GC; Fratz, EJ; Hunter, GA1
Ozer, U1

Reviews

1 review(s) available for deferoxamine and paclitaxel

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for deferoxamine and paclitaxel

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Apoptotic cell death induced by taxol is inhibited by nitric oxide in human leukemia HL-60 cells.
    Immunopharmacology and immunotoxicology, 1999, Volume: 21, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Deferoxamine; DNA Fragmentation; G1 Phase; Glutathione; Growth Inhibitors; HL-60 Cells; Humans; Mimosine; Nitric Oxide; Nitroso Compounds; Paclitaxel; S Phase; S-Nitrosoglutathione

1999
Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Aldehydes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cyclophosphamide; Deferoxamine; Doxorubicin; Drug Synergism; Fluorouracil; Humans; Hydrazones; Iron Chelating Agents; MCF-7 Cells; Methotrexate; Paclitaxel; Tamoxifen; Thiosemicarbazones

2014
Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: 5-Aminolevulinate Synthetase; Animals; Cell Death; Cell Membrane; Culture Media; Deferoxamine; Glycine; Green Fluorescent Proteins; HeLa Cells; Humans; K562 Cells; Light; Mice; Mutant Proteins; Paclitaxel; Plasmids; Protoporphyrins; Transfection

2014
The role of Iron on breast cancer stem-like cells.
    Cellular and molecular biology (Noisy-le-Grand, France), 2016, Apr-30, Volume: 62, Issue:4

    Topics: Breast Neoplasms; Cell Count; Cell Line, Tumor; Cell Survival; Deferoxamine; Epithelial Cells; Female; Humans; Iron; Iron Chelating Agents; Neoplastic Stem Cells; Paclitaxel; Receptor, ErbB-2

2016